QA: Oruka Therapeutics Inc in us_medicinal_products/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000907654_2019_Oruka_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000907654, Oruka Therapeutics Inc

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 793,000
2 remainder_Liabilities 0
3 AssetsCurrent 6,777,000
4 AssetsNoncurrent 24,000
5 PropertyPlantAndEquipmentNet 24,000
6 Goodwill 0
7 remainder_Assets 0
8 GeneralAndAdministrativeExpense 3,879,000
9 ResearchAndDevelopmentExpense 4,239,000
10 remainder_Expenses -23,000
11 remainder_Revenues 162,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 2,000
  yvar yval
0 Liabilities 793,000
1 Assets 6,825,000
2 Expenses 8,095,000
3 Revenues 162,000
4 StockholdersEquity 6,032,000
5 NetIncome -7,933,000
6 ComprehensiveNetIncome -7,932,000
7 BaseVar 7,938,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.0871
9 EconomicCapitalRatio 0.932

Edgar->Model Mapping

Feature Distribution

Change over Time